Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (20)

2021

  1. Raccoons (Procyon lotor) in the Madrid region of Spain are carriers of antimicrobial-resistant Escherichia coli and enteropathogenic E. coli

    Zoonoses and Public Health, Vol. 68, Núm. 2, pp. 69-78

2015

  1. HisAK70: Progress towards a vaccine against different forms of leishmaniosis

    Parasites and Vectors, Vol. 8, Núm. 1

2014

  1. Characterisation of the ex vivo virulence of Leishmania infantum isolates from Phlebotomus perniciosus from an outbreak of human leishmaniosis in Madrid, Spain

    Parasites and Vectors, Vol. 7, Núm. 1

2012

  1. Mitigating an undesirable immune response of inherent susceptibility to cutaneous leishmaniosis in a mouse model: The role of the pathoantigenic HISA70 DNA vaccine

    Veterinary Research, Vol. 43, Núm. 1

  2. The receptor Slamf1 on the surface of myeloid lineage cells controls susceptibility to infection by Trypanosoma cruzi

    PLoS Pathogens, Vol. 8, Núm. 7, pp. 38

2011

  1. Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: A preliminary evaluation

    Parasites and Vectors, Vol. 4, Núm. 1

  2. Mechanisms of resistance and susceptibility to experimental visceral leishmaniosis: BALB/c mouse versus syrian hamster model

    Veterinary Research, Vol. 42, Núm. 1

2009

  1. Development of Immunization Strategies against Leishmaniosis based on the Leishmania Histones Pathoantigens

    Procedia in Vaccinology, Vol. 1, Núm. 1, pp. 101-103

2008

  1. Immunization strategies against visceral leishmaniosis with the nucleosomal histones of Leishmania infantum encoded in DNA vaccine or pulsed in dendritic cells

    Vaccine, Vol. 26, Núm. 20, pp. 2537-2544

  2. Transitory or long-lasting immunity to Leishmania major infection: The result of immunogenicity and multicomponent properties of histone DNA vaccines

    Vaccine, Vol. 26, Núm. 9, pp. 1155-1165

2007

  1. Adoptive transfer of dendritic cells pulsed with Leishmania infantum nucleosomal histones confers protection against cutaneous leishmaniosis in BALB/c mice

    Microbes and Infection, Vol. 9, Núm. 6, pp. 735-743

  2. Role of Trypanosoma cruzi autoreactive T cells in the generation of cardiac pathology

    Annals of the New York Academy of Sciences

  3. The immunodominant T helper 2 (Th2) response elicited in BALB/c mice by the Leishmania LiP2a and LiP2b acidic ribosomal proteins cannot be reverted by strong Th1 inducers

    Clinical and Experimental Immunology, Vol. 150, Núm. 2, pp. 375-385

2006

  1. Immunohistological features of visceral leishmaniasis in BALB/c mice

    Parasite Immunology, Vol. 28, Núm. 5, pp. 173-183

  2. The efficacy of photochemical treatment with methylene blue and light for the reduction of Trypanosoma cruzi in infected plasma

    Vox Sanguinis, Vol. 91, Núm. 4, pp. 285-291

2005

  1. Pentamidine is an antiparasitic and apoptotic drug that selectively modifies ubiquitin

    Chemistry and Biodiversity, Vol. 2, Núm. 10, pp. 1387-1400

  2. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice

    Infection and Immunity, Vol. 73, Núm. 9, pp. 5842-5852

2004

  1. Recent advances in vaccines for leishmaniasis

    Expert Opinion on Biological Therapy, Vol. 4, Núm. 9, pp. 1505-1517

  2. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis

    Vaccine, Vol. 22, Núm. 29-30, pp. 3865-3876

2003

  1. The Leishmania infantum Acidic Ribosomal Protein P0 Administered as a DNA Vaccine Confers Protective Immunity to Leishmania major Infection in BALB/c Mice

    Infection and Immunity, Vol. 71, Núm. 11, pp. 6562-6572